Repurposing Statins for Renal Protection: Is It a Class Effect?
Key result
Statins show potential to prevent contrast-induced nephropathy but not postcardiac surgery AKI.
Why the study?
Do statins prevent acute kidney injury in patients exposed to cardiac surgery, contrast media, or aminoglycosides?
Population
Patients at risk of acute kidney injury, specifically those undergoing cardiac surgery, receiving contrast…
Comparison
Statins. vs No statin therapy or standard of care.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May support statin consideration for contrast-induced nephropathy prevention; leaves open efficacy in other AKI settings and need for targeted RCTs.
Structured PICO
Do statins prevent acute kidney injury in patients exposed to cardiac surgery, contrast media, or aminoglycosides?
P
Population
Patients at risk of acute kidney injury, specifically those undergoing cardiac surgery, receiving contrast media, or treated with aminoglycoside antibiotics.
I
Intervention
Statins (including rosuvastatin, atorvastatin, and simvastatin).
C
Comparator
No statin therapy or standard of care.
O
Outcome
Prevention of acute kidney injury or nephrotoxicity.hard clinical
Statins may offer renal protection in specific settings like contrast-induced nephropathy, but efficacy likely depends on the individual statin's pharmacokinetics and the specific mechanism of renal injury.
Limitations
- Assuming a class effect for statins in repurposed indications is incorrect due to differing pharmacokinetics and pleiotropic effects.
- Further preclinical and dose-ranging studies are needed to identify the correct statin and dose for each new indication.
- Previous meta-analyses grouped all statins together despite differences in pharmacokinetics, potency, and dose-response profiles.
- Lack of mechanistic insight and careful analysis of dose-response relationships in existing literature.
Cite This Study
McWilliam et al. (2017) conducted an editorial in Renal injury (cardiac surgery, contrast-induced nephropathy, aminoglycoside-induced nephrotoxicity). Statins was evaluated. Statins show potential for repurposing in renal protection, with evidence supporting their use in contrast-induced nephropathy but not in preventing postcardiac surgery acute kidney injury.